Most recently, it's been discovered that conolidine and the above mentioned derivatives act about the atypical chemokine receptor three (ACKR3. Expressed in equivalent areas as classical opioid receptors, it binds into a big range of endogenous opioids. Contrary to most opioid receptors, this receptor acts for a scavenger and does not activate a se